The pulmonary excretion of14CO2 in patients with ileal resection, Crohn's disease and control subjects following administration of glycine-1-14C

1974 ◽  
Vol 30 (12) ◽  
pp. 1429-1430
Author(s):  
A. Belfield ◽  
V. Melikian ◽  
K. P. Rao ◽  
P. O. Stokes ◽  
W. T. Cooke
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Ileal Resection ◽  
Control Subjects ◽  
And Control ◽  
Pulmonary Excretion

scholarly journals Alterations in lipid, amino acid, and energy metabolism distinguish Crohn’s disease from ulcerative colitis and control subjects by serum metabolomic profiling

Metabolomics ◽  
2017 ◽  
Vol 14 (1) ◽  
Author(s):  
Elizabeth A. Scoville ◽  
Margaret M. Allaman ◽  
Caroline T. Brown ◽  
Amy K. Motley ◽  
Sara N. Horst ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Crohn’S Disease ◽  
Amino Acid ◽  
Energy Metabolism ◽  
Crohn's Disease ◽  
Control Subjects ◽  
Metabolomic Profiling ◽  
And Control

Incidence of Mycobacterium avium Subspecies paratuberculosis in a Population-Based Cohort of Patients With Crohn's Disease and Control Subjects

2008 ◽  
Vol 103 (5) ◽  
pp. 1168-1172 ◽  
Author(s):  
Robert W. Bentley ◽  
Jacqui I. Keenan ◽  
Richard B. Gearry ◽  
Martin A. Kennedy ◽  
Murray L. Barclay ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Mycobacterium Avium ◽  
Mycobacterium Avium Subspecies Paratuberculosis ◽  
Population Based ◽  
Control Subjects ◽  
And Control

P.58 FECAL DETECTION OF MYCOBACTERIUM AVIUM PARATUBERCOLOSIS (MAP) USING IS900 DNA SEQUENCE IN CROHN'S DISEASE AND CONTROL SUBJECTS

2010 ◽  
Vol 42 ◽  
pp. S123-S124
Author(s):  
A. Tuci ◽  
G. Roda ◽  
F. Tonon ◽  
L. Castellani ◽  
A. Caponi ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Dna Sequence ◽  
Mycobacterium Avium ◽  
Control Subjects ◽  
And Control

scholarly journals Crohn's disease recurrence can be prevented after ileal resection

Gut ◽  
2002 ◽  
Vol 51 (2) ◽  
pp. 152-153 ◽  
Author(s):  
P Rutgeerts
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Disease Recurrence ◽  
Ileal Resection

scholarly journals Strategies for Preventing Endoscopic Recurrence of Crohn’s Disease 1 Year after Surgery: A Network Meta-Analysis

2017 ◽  
Vol 2017 ◽  
pp. 1-8 ◽  
Author(s):  
Jin-shan Feng ◽  
Jin-yu Li ◽  
Xiu-yan Chen ◽  
Zheng Yang ◽  
Shang-hai Li
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Meta Analysis ◽  
Credible Interval ◽  
Ileal Resection ◽  
Randomized Controlled ◽  
Endoscopic Recurrence ◽  
Central Database ◽  
Lactobacillus Gg

Objective. To assess the benefits of different treatments that aim to prevent the endoscopic recurrence of Crohn’s disease (CD) after ileal resection. Methods. Randomized controlled trials (RCTs) were searched from MEDLINE, Embase, and the Cochrane Central Database. All the included RCTs with an endoscopic recurrence outcome which was defined as Rutgeerts’ score ≥ i2 have a duration of more than 1 year. The quality of the included RCTs was assessed by the Cochrane Risk of Bias Tool. Pairwise treatment effects were estimated through a Bayesian random effects network meta-analysis by using the OpenBUGS 1.4 software and reported as odds ratios (ORs) with a 95% credible interval (CI). Results. Fourteen RCTs (877 participants) were included. Two strategies were superior to placebo for preventing endoscopic recurrence of CD at 1 year after surgery: infliximab (d, −5.475; 95% CI, −10.47 to –1.632) and adalimumab (d, −7.273; 95% CI, −13.84 to −2.585). Nine strategies were not effective: budesnoid, mesalazine (in both high and low dose), azathioprine, Tripterygium wilfordii, mesalazine + infliximab, ornidazole, untreated intervention, and Lactobacillus GG. Conclusions. Except for infliximab and adalimumab, other strategies included in our analysis were not effective for preventing endoscopic recurrence of CD at 1 year after ileal resection.

Sign in / Sign up

Export Citation Format

Share Document